2-oxoimidazolidine-4-carboxamides as Nav1.8 inhibitors
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Na
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SHAH, Akshay A BELL, Ian M BURGEY, Christopher S PERKINS, James J COX, Jason M LIU, Jian ARASAPPAN, Ashok WU, Zhe KELLY III, Michael J LAYTON, Mark E LIU, Hong BUNGARD, Christopher James VANHEYST, Michael David |
| description | Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Na |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021293176A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021293176A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021293176A13</originalsourceid><addsrcrecordid>eNrjZDAz0s2vyM_MzUxJrMrPyUzJzEvVNdFNTixKyq9IBIqmFiskFiv4JZYZ6lkoZOZlZCZlluQXFfMwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUknjHUCMDI0MjS2NDczNHQ2PiVAEABBwtsQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-oxoimidazolidine-4-carboxamides as Nav1.8 inhibitors</title><source>esp@cenet</source><creator>SHAH, Akshay A ; BELL, Ian M ; BURGEY, Christopher S ; PERKINS, James J ; COX, Jason M ; LIU, Jian ; ARASAPPAN, Ashok ; WU, Zhe ; KELLY III, Michael J ; LAYTON, Mark E ; LIU, Hong ; BUNGARD, Christopher James ; VANHEYST, Michael David</creator><creatorcontrib>SHAH, Akshay A ; BELL, Ian M ; BURGEY, Christopher S ; PERKINS, James J ; COX, Jason M ; LIU, Jian ; ARASAPPAN, Ashok ; WU, Zhe ; KELLY III, Michael J ; LAYTON, Mark E ; LIU, Hong ; BUNGARD, Christopher James ; VANHEYST, Michael David</creatorcontrib><description>Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Na</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230202&DB=EPODOC&CC=AU&NR=2021293176A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230202&DB=EPODOC&CC=AU&NR=2021293176A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHAH, Akshay A</creatorcontrib><creatorcontrib>BELL, Ian M</creatorcontrib><creatorcontrib>BURGEY, Christopher S</creatorcontrib><creatorcontrib>PERKINS, James J</creatorcontrib><creatorcontrib>COX, Jason M</creatorcontrib><creatorcontrib>LIU, Jian</creatorcontrib><creatorcontrib>ARASAPPAN, Ashok</creatorcontrib><creatorcontrib>WU, Zhe</creatorcontrib><creatorcontrib>KELLY III, Michael J</creatorcontrib><creatorcontrib>LAYTON, Mark E</creatorcontrib><creatorcontrib>LIU, Hong</creatorcontrib><creatorcontrib>BUNGARD, Christopher James</creatorcontrib><creatorcontrib>VANHEYST, Michael David</creatorcontrib><title>2-oxoimidazolidine-4-carboxamides as Nav1.8 inhibitors</title><description>Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Na</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAz0s2vyM_MzUxJrMrPyUzJzEvVNdFNTixKyq9IBIqmFiskFiv4JZYZ6lkoZOZlZCZlluQXFfMwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUknjHUCMDI0MjS2NDczNHQ2PiVAEABBwtsQ</recordid><startdate>20230202</startdate><enddate>20230202</enddate><creator>SHAH, Akshay A</creator><creator>BELL, Ian M</creator><creator>BURGEY, Christopher S</creator><creator>PERKINS, James J</creator><creator>COX, Jason M</creator><creator>LIU, Jian</creator><creator>ARASAPPAN, Ashok</creator><creator>WU, Zhe</creator><creator>KELLY III, Michael J</creator><creator>LAYTON, Mark E</creator><creator>LIU, Hong</creator><creator>BUNGARD, Christopher James</creator><creator>VANHEYST, Michael David</creator><scope>EVB</scope></search><sort><creationdate>20230202</creationdate><title>2-oxoimidazolidine-4-carboxamides as Nav1.8 inhibitors</title><author>SHAH, Akshay A ; BELL, Ian M ; BURGEY, Christopher S ; PERKINS, James J ; COX, Jason M ; LIU, Jian ; ARASAPPAN, Ashok ; WU, Zhe ; KELLY III, Michael J ; LAYTON, Mark E ; LIU, Hong ; BUNGARD, Christopher James ; VANHEYST, Michael David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021293176A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SHAH, Akshay A</creatorcontrib><creatorcontrib>BELL, Ian M</creatorcontrib><creatorcontrib>BURGEY, Christopher S</creatorcontrib><creatorcontrib>PERKINS, James J</creatorcontrib><creatorcontrib>COX, Jason M</creatorcontrib><creatorcontrib>LIU, Jian</creatorcontrib><creatorcontrib>ARASAPPAN, Ashok</creatorcontrib><creatorcontrib>WU, Zhe</creatorcontrib><creatorcontrib>KELLY III, Michael J</creatorcontrib><creatorcontrib>LAYTON, Mark E</creatorcontrib><creatorcontrib>LIU, Hong</creatorcontrib><creatorcontrib>BUNGARD, Christopher James</creatorcontrib><creatorcontrib>VANHEYST, Michael David</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHAH, Akshay A</au><au>BELL, Ian M</au><au>BURGEY, Christopher S</au><au>PERKINS, James J</au><au>COX, Jason M</au><au>LIU, Jian</au><au>ARASAPPAN, Ashok</au><au>WU, Zhe</au><au>KELLY III, Michael J</au><au>LAYTON, Mark E</au><au>LIU, Hong</au><au>BUNGARD, Christopher James</au><au>VANHEYST, Michael David</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-oxoimidazolidine-4-carboxamides as Nav1.8 inhibitors</title><date>2023-02-02</date><risdate>2023</risdate><abstract>Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Na</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2021293176A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | 2-oxoimidazolidine-4-carboxamides as Nav1.8 inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T22%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHAH,%20Akshay%20A&rft.date=2023-02-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021293176A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |